Complement C5a potentiates uric acid crystal-induced IL-1β production

被引:60
作者
An, Ling-Ling [1 ]
Mehta, Payal [1 ]
Xu, Linda [2 ]
Turman, Sean [1 ]
Reimer, Thornik [1 ]
Naiman, Brian [1 ]
Connor, Jane [1 ]
Sanjuan, Miguel [1 ]
Kolbeck, Roland [1 ]
Fung, Michael [1 ]
机构
[1] MedImmune LLC, Dept Resp Inflammat & Autoimmune Dis, Gaithersburg, MD USA
[2] MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD USA
关键词
C5a; Gout; Inflammasome; IL-1; beta; monosodium urate/; uric acid (MSU) crystal; Priming; MEMBRANE ATTACK COMPLEX; NLRP3; INFLAMMASOME; ALTERNATIVE PATHWAY; GOUTY-ARTHRITIS; CUTTING EDGE; ACTIVATION; PHAGOCYTOSIS; RECEPTOR; INTERLEUKIN-1-BETA; RELEASE;
D O I
10.1002/eji.201444560
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Anaphylatoxin C5a released upon complement activation is associated with both acute and chronic inflammations such as gout. The pathogenesis of gout was identified as uric acid crystal deposition in the joints that activates inflammasome, leading to IL-1 beta release. However, little is known about the interaction between complement activation and monosodium urate/uric acid (MSU) crystal-induced inflammasome activation or IL-1 beta production. Here, we report that MSU crystal-induced proinflammatory cytokines/chemokines in human whole blood is predominantly regulated by C5a through its interaction with C5a receptor. C5a induces pro-IL-1 beta and IL-1 beta production in human primary monocytes, and potentiates MSU or cholesterol crystals in IL-1 beta production. This potentiation is caspase-1 dependent and requires intracellular Ca2+ mobilization, K+ efflux, and cathepsin B activity. Our results provide insight into the role of C5a as an endogenous priming signal that is required for the initiation of uric acid crystal-induced IL-1 beta production. C5a could potentially be a therapeutic target together with IL-1 beta antagonists for the treatment of complement-dependent and inflammasome-associated diseases.
引用
收藏
页码:3669 / 3679
页数:11
相关论文
共 43 条
[1]   Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome [J].
Bauernfeind, Franz ;
Bartok, Eva ;
Rieger, Anna ;
Franchi, Luigi ;
Nunez, Gabriel ;
Hornung, Veit .
JOURNAL OF IMMUNOLOGY, 2011, 187 (02) :613-617
[2]   Mechanisms of inflammation in gout [J].
Busso, Nathalie ;
So, Alexander .
ARTHRITIS RESEARCH & THERAPY, 2010, 12 (02)
[3]   MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals [J].
Chen, Chun-Jen ;
Shi, Yan ;
Hearn, Arron ;
Fitzgerald, Kate ;
Golenbock, Douglas ;
Reed, George ;
Akira, Shizuo ;
Rock, Kenneth L. .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (08) :2262-2271
[4]   ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT BY MONOSODIUM URATE MONOHYDRATE CRYSTALS AND OTHER INFLAMMATORY PARTICLES [J].
DOHERTY, M ;
WHICHER, JT ;
DIEPPE, PA .
ANNALS OF THE RHEUMATIC DISEASES, 1983, 42 (03) :285-291
[5]   NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals [J].
Duewell, Peter ;
Kono, Hajime ;
Rayner, Katey J. ;
Sirois, Cherilyn M. ;
Vladimer, Gregory ;
Bauernfeind, Franz G. ;
Abela, George S. ;
Franchi, Luigi ;
Nunez, Gabriel ;
Schnurr, Max ;
Espevik, Terje ;
Lien, Egil ;
Fitzgerald, Katherine A. ;
Rock, Kenneth L. ;
Moore, Kathryn J. ;
Wright, Samuel D. ;
Hornung, Veit ;
Latz, Eicke .
NATURE, 2010, 464 (7293) :1357-U7
[6]   ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT BY MONOSODIUM URATE CRYSTALS [J].
FIELDS, TR ;
ABRAMSON, SB ;
WEISSMANN, G ;
KAPLAN, AP ;
GHEBREHIWET, B .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1983, 26 (02) :249-257
[7]   Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage [J].
Fung, M ;
Lu, M ;
Fure, H ;
Sun, W ;
Sun, C ;
Shi, NY ;
Dou, Y ;
Su, J ;
Swanson, X ;
Mollnes, TE .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 133 (02) :160-169
[8]   Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1β by mononuclear cells through a caspase 1-mediated process [J].
Giamarellos-Bourboulis, E. J. ;
Mouktaroudi, M. ;
Bodar, E. ;
van der Ven, J. ;
Kullberg, B-J ;
Netea, M. G. ;
van der Meer, J. W. M. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (02) :273-278
[9]  
GOLDSTEIN I, 1986, PATHOL BIOL, V34, P841
[10]   HUMAN RECOMBINANT C5A ENHANCES LIPOPOLYSACCHARIDE-INDUCED SYNTHESIS OF INTERLEUKIN-6 BY HUMAN MONOCYTES [J].
GROSS, V ;
ANDUS, T .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1992, 22 (04) :271-276